… failure of therapy. Considering the immense therapeutic potential of miRNA in cancers particularly
… deliver the therapeutic miRNAs to the tumor cells by overcoming the barriers in PDAC. …

… for 90% of pancreatic cancer cases. Neoplasms arising from … of pancreatic cancer cells
to chemo and radiation therapies. … , prognostic and therapeutic targets in pancreatic cancer. …

… for finding novel potential therapeutic drugs. … potential natural products for pancreatic
cancer treatment, we comprehensively addressed the natural products and some major anti-cancer …

… Nonetheless, no bacterial species have emerged as being therapeutic for pancreatic cancer,
and bacteriotherapy for this cancer remains largely unexplored. However, being mindful of …

… Recent study further addressed the therapeutic potential of class I and class II selective
HDAC inhibitors on cell cycle progression in pancreatic cancer cell lines. Treatment with class I …

… Over past few decades, scientists have focused on therapeutic potentials of curcumin due to
… therapeutic potential of this promising agent in treatment of patients with pancreatic cancer. …

Most patients with pancreatic ductal adenocarcinoma (PDAC) present with unresectable or
metastatic disease with very poor prognosis. Chemotherapy is the primary treatment modality …

Purpose Pancreatic cancer (PC) is one of the deadliest of all tumors. Previously, we were
the first to show that Thymoquinone (TQ) derived from black seed (Nigella sativa) oil has anti-…

… In summary, this study demonstrated that TPX2 silencing has a novel therapeutic potential
in pancreatic cancer. The upregulation of IGFBP-3 induced by TPX2 silencing may be at least …

… of nanoparticles as an emerging therapy for pancreatic cancer. The Preferred Reporting Items
… as a therapeutic or prognostic option in patients with pancreatic cancer were considered. …